share_log

Benchmark Reiterates Buy on Surgery Partners, Maintains $50 Price Target

Benzinga ·  May 1 11:17

Benchmark analyst Bill Sutherland reiterates Surgery Partners (NASDAQ:SGRY) with a Buy and maintains $50 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment